Burning Rock Biotech (BNR) Research & Development (2019 - 2025)

Burning Rock Biotech's Research & Development history runs 7 years deep, the most recent figure standing at -$5.0 million for Q4 2025.

• In Q4 2025, Research & Development rose 30.29% year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$23.3 million (up 27.64% YoY), while the FY2025 annual figure was $23.8 million, down 25.19% from the prior year.
• Research & Development was -$5.0 million for Q4 2025 at Burning Rock Biotech, up from -$5.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$5.0 million in Q4 2025 to a low of -$18.8 million in Q1 2022.
• Historically, Research & Development has averaged -$11.2 million across 5 years, with a median of -$11.1 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Research & Development sank 106.08% in 2021, then surged 39.1% in 2025.
• A 5-year view of Research & Development shows it stood at -$17.7 million in 2021, then increased by 17.36% to -$14.6 million in 2022, then rose by 29.55% to -$10.3 million in 2023, then soared by 30.56% to -$7.2 million in 2024, then soared by 30.29% to -$5.0 million in 2025.
• The last three Research & Development figures came in at -$5.0 million (Q4 2025), -$5.8 million (Q3 2025), and -$6.9 million (Q2 2025), per Business Quant data.